Gao, T., Wang, Z., Dong, Y., Cao, J
Any aggressive fat-loss protocol carries a risk of dropping lean mass along with fat
Stress during pregnancy alters temporal and spatial dynamics of the maternal and offspring microbiome in a sex-specific manner
Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Compared with ipamorelin, GHRP-2 is often discussed as a stronger or more aggressive secretagogue, depending on the model, dose, and study design
The 2003 ESHRE/ASRM-sponsored Rotterdam consensus established the diagnostic framework for PCOS based on combinations of oligo-ovulation, hyperandrogenism, and polycystic ovarian morphology